HFA 2023: Unlocking the Potential of Baroreflex Activation in Heart Failure Patients

Unlocking the Potential of Baroreflex Activation Therapy (BAT) at HFA 2023.
Baroreflex Activation Therapy (BAT) is delivered through Barostim, an implantable pulse generator (IPG). Barostim rebalances the autonomic nervous system by delivering continuous electrical stimulation to carotid baroreceptors, improving heart failure symptoms.
Barostim is an option to improve exercise capacity in the 70% of patients not indicated for CRT.
For More Information: CVRx.com/healthcare-professionals/
See The Clinical Data: CVRx.com/healthcare-professionals/beat-hf-trial/

[@larryjustice299]

Duke Heart Center in the last 2 years "watched" my HF worsen from >55% EF to 30% and further demise to 23% before I could get seen and repeat documentation for heart care. I have had heart failure since '98 and this was the second time I let DUKE Heart Center provide what should be criminal level care. My Duke heart "doctor" made statement after my demise from >55% to

[@hemphillmb]

Did you qualify for barostim?